New Binding Sites, New Opportunities for GPCR Drug Discovery.

Trends Biochem Sci

Biological and Chemical Research Centre, University of Warsaw, ul. Żwirki i Wigury 101, Warsaw 02-089, Poland; Laboratory of Physical Chemistry of Polymers and Membranes, Ecole Polytechnique Fédérale de Lausanne (EPFL), CH B3 495 (Bâtiment CH) Station 6, Lausanne CH-1015, Switzerland. Electronic address:

Published: April 2019

Many central biological events rely on protein-ligand interactions. The identification and characterization of protein-binding sites for ligands are crucial for the understanding of functions of both endogenous ligands and synthetic drug molecules. G protein-coupled receptors (GPCRs) typically detect extracellular signal molecules on the cell surface and transfer these chemical signals across the membrane, inducing downstream cellular responses via G proteins or β-arrestin. GPCRs mediate many central physiological processes, making them important targets for modern drug discovery. Here, we focus on the most recent breakthroughs in finding new binding sites and binding modes of GPCRs and their potentials for the development of new medicines.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.tibs.2018.11.011DOI Listing

Publication Analysis

Top Keywords

binding sites
8
drug discovery
8
sites opportunities
4
opportunities gpcr
4
gpcr drug
4
discovery central
4
central biological
4
biological events
4
events rely
4
rely protein-ligand
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!